论文部分内容阅读
目的:对尿激酶溶栓治疗心源性脑梗塞的临床效果进行分析。方法:选择2013年1月-2015年12月本院收治的符合临床诊断标准的心源性脑梗塞患者98例作为研究对象,按照治疗方式的不同分成对照组和观察组,分别接受常规治疗和常规治疗基础上的尿激酶溶栓治疗。结果:观察组患者治疗1、3、5、7、14 d后,神经功能缺损评分相对于治疗前发生显著改善(P<0.05),对照组患者治疗1、3、5 d后,相对于治疗前神经功能缺损评分无明显改善(P>0.05)。观察组患者治疗后的不同阶段,神经功能缺损评分均优于对照组(P<0.05);观察组治疗有效率明显高于对照组(P<0.05)。结论:对心源性脑梗塞患者在常规治疗的基础上,采取尿激酶溶栓治疗的效果显著,可有效改善患者神经功能恢复。
Objective: To analyze the clinical effect of urokinase thrombolytic therapy on cardio-cerebral infarction. Methods: From January 2013 to December 2015, 98 patients with cardiogenic cerebral infarction who met the clinical diagnostic criteria in our hospital were selected as the research object and divided into control group and observation group according to the different treatment methods, and received routine treatment and Routine treatment based on urokinase thrombolysis. Results: After 1, 3, 5, 7 and 14 days of treatment, the score of neurological deficit in observation group was significantly improved compared with that before treatment (P <0.05). In the control group, The score of anterior neurological deficit had no significant improvement (P> 0.05). Neurological deficit scores of observation group were better than that of control group at different stages after treatment (P <0.05). The effective rate of observation group was significantly higher than that of control group (P <0.05). Conclusion: Based on the routine treatment of patients with cardio-cerebral infarction, the effect of thrombolysis with urokinase is significant, which can effectively improve the recovery of neurological function.